Comparative Study of the Antithrombotic Effects of Ticagrelor and Clopidogrel in Type 2 Diabetic Patients
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2016
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; Aspirin
- Indications Thrombosis
- Focus Therapeutic Use
- 13 Apr 2016 Status changed from recruiting to completed.
- 05 May 2015 Planned End Date changed from 1 May 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.
- 12 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.